RUBINSTEIN JULIE — SEC insider filings
SEC reporting owner CIK 1780664. 60 insider filings on record with FilingPulse; latest filed 2026-11-13.
Transaction summary — filings shown
Covers the 50 most recent of 60 filings on record, filed 2021-01-20 to 2026-11-13. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 193 legs across 48 filings — 1,904,715 shares, $51,994,602 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 233.
- Largest priced transaction: sale of 122,523 shares @ $13.17 ($1,613,628) in Adaptive Biotechnologies Corp, filed 2026-03-13.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Adaptive Biotechnologies Corp (ADPT) | President and COO | 50 | — | 193 legs · 1,904,715 sh · $51,994,602 | 233 |
Insider filings — RUBINSTEIN JULIE
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-11-13 | 4 | Adaptive Biotechnologies Corp (ADPT) | Option exercise (M): 11,881 @ $12.14 · Sale (S): 4,983 @ $30.29 · Sale (S): 6,898 @ $31.22 · Option exercise (M): 11,881 @ $12.14 · Sale (S): 11,881 @ $29.40 · Option exercise (M): 11,466 @ $12.14 · +4 more | EDGAR |
| 2026-11-10 | 4 | Adaptive Biotechnologies Corp (ADPT) | Option exercise (M): 11,881 @ $12.14 · Sale (S): 1,100 @ $28.87 · Sale (S): 8,381 @ $30.15 · Sale (S): 2,400 @ $30.58 · Option exercise (M): 11,881 @ $12.14 · Sale (S): 9,981 @ $29.35 · +3 more | EDGAR |
| 2026-11-06 | 4 | Adaptive Biotechnologies Corp (ADPT) | Option exercise (M): 11,881 @ $12.14 · Sale (S): 4,000 @ $25.78 · Sale (S): 7,881 @ $26.60 · Option exercise (M): 11,881 @ $12.14 · Sale (S): 5,926 @ $26.10 · Sale (S): 5,455 @ $26.88 · +7 more | EDGAR |
| 2026-11-03 | 4 | Adaptive Biotechnologies Corp (ADPT) | Option exercise (M): 11,881 @ $12.14 · Sale (S): 9,486 @ $26.55 · Sale (S): 2,395 @ $27.45 · Option exercise (M): 11,881 @ $12.14 · Sale (S): 9,296 @ $25.23 · Sale (S): 2,585 @ $26.34 · +5 more | EDGAR |
| 2026-10-29 | 4 | Adaptive Biotechnologies Corp (ADPT) | Option exercise (M): 11,881 @ $12.14 · Sale (S): 3,000 @ $26.58 · Sale (S): 8,881 @ $27.53 · Option exercise (M): 11,881 @ $12.14 · Sale (S): 11,681 @ $28.44 · Sale (S): 200 @ $28.90 · +5 more | EDGAR |
| 2026-10-26 | 4 | Adaptive Biotechnologies Corp (ADPT) | Option exercise (M): 11,881 @ $12.14 · Sale (S): 10,181 @ $24.38 · Sale (S): 1,700 @ $25.29 · Option exercise (M): 11,881 @ $12.14 · Sale (S): 4,500 @ $24.50 · Sale (S): 7,381 @ $25.28 · +6 more | EDGAR |
| 2026-10-21 | 4 | Adaptive Biotechnologies Corp (ADPT) | Option exercise (M): 11,881 @ $12.14 · Sale (S): 11,881 @ $24.05 · Option exercise (M): 11,881 @ $12.14 · Sale (S): 11,781 @ $24.53 · Sale (S): 100 @ $24.85 · Option exercise (M): 11,881 @ $12.14 · +5 more | EDGAR |
| 2026-10-16 | 4 | Adaptive Biotechnologies Corp (ADPT) | Option exercise (M): 11,881 @ $12.14 · Sale (S): 6,781 @ $25.57 · Sale (S): 5,100 @ $25.82 · Option exercise (M): 11,881 @ $12.14 · Sale (S): 11,881 @ $25.61 · Option exercise (M): 11,881 @ $12.14 · +5 more | EDGAR |
| 2026-10-13 | 4 | Adaptive Biotechnologies Corp (ADPT) | Option exercise (M): 11,881 @ $12.14 · Sale (S): 11,881 @ $26.41 · Option exercise (M): 11,881 @ $12.14 · Sale (S): 9,181 @ $25.35 · Sale (S): 2,700 @ $26.07 · Option exercise (M): 11,881 @ $12.14 · +4 more | EDGAR |
| 2026-10-08 | 4 | Adaptive Biotechnologies Corp (ADPT) | Option exercise (M): 11,881 @ $12.14 · Sale (S): 9,381 @ $27.36 · Sale (S): 1,100 @ $28.21 · Sale (S): 901 @ $29.71 · Sale (S): 499 @ $30.53 · Option exercise (M): 11,881 @ $12.14 · +6 more | EDGAR |
| 2026-10-05 | 4 | Adaptive Biotechnologies Corp (ADPT) | Option exercise (M): 11,881 @ $12.14 · Sale (S): 6,081 @ $27.57 · Sale (S): 5,800 @ $28.56 · Option exercise (M): 11,881 @ $12.14 · Sale (S): 11,881 @ $28.13 · Option exercise (M): 11,881 @ $12.14 · +5 more | EDGAR |
| 2026-04-29 | 4 | Adaptive Biotechnologies Corp (ADPT) | Option exercise (M): 14,707 @ $8.46 · Sale (S): 19,037 @ $14.23 · Option exercise (M): 14,707 (derivative) @ $0 | EDGAR |
| 2026-04-24 | 4 | Adaptive Biotechnologies Corp (ADPT) | Option exercise (M): 14,722 @ $8.46 · Sale (S): 19,060 @ $14.13 · Option exercise (M): 14,722 @ $8.46 · Sale (S): 19,060 @ $13.74 · Option exercise (M): 14,722 @ $8.46 · Sale (S): 19,060 @ $14.02 · +3 more | EDGAR |
| 2026-04-21 | 4 | Adaptive Biotechnologies Corp (ADPT) | Option exercise (M): 14,722 @ $8.46 · Sale (S): 19,060 @ $14.57 · Option exercise (M): 14,722 @ $8.46 · Sale (S): 19,060 @ $14.55 · Option exercise (M): 14,722 @ $8.46 · Option exercise (M): 11,881 @ $12.14 · +5 more | EDGAR |
| 2026-04-16 | 4 | Adaptive Biotechnologies Corp (ADPT) | Option exercise (M): 14,722 @ $8.46 · Sale (S): 19,060 @ $14.56 · Option exercise (M): 14,722 @ $8.46 · Sale (S): 19,060 @ $14.61 · Option exercise (M): 14,722 @ $8.46 · Sale (S): 19,060 @ $14.18 · +3 more | EDGAR |
| 2026-04-13 | 4 | Adaptive Biotechnologies Corp (ADPT) | Option exercise (M): 14,722 @ $7.27 · Sale (S): 16,960 @ $13.79 · Sale (S): 2,100 @ $14.44 · Option exercise (M): 14,722 @ $7.27 · Sale (S): 18,660 @ $12.75 · Sale (S): 400 @ $13.48 · +8 more | EDGAR |
| 2026-04-08 | 4 | Adaptive Biotechnologies Corp (ADPT) | Option exercise (M): 14,722 @ $7.27 · Sale (S): 19,060 @ $14.33 · Option exercise (M): 14,722 @ $7.27 · Sale (S): 19,060 @ $13.56 · Option exercise (M): 14,722 @ $7.27 · Option exercise (M): 11,881 @ $12.14 · +6 more | EDGAR |
| 2026-04-02 | 4 | Adaptive Biotechnologies Corp (ADPT) | Option exercise (M): 14,722 @ $7.27 · Sale (S): 19,060 @ $14.45 · Option exercise (M): 14,722 @ $7.27 · Sale (S): 19,060 @ $14.60 · Option exercise (M): 14,722 (derivative) @ $0 · Option exercise (M): 14,722 (derivative) @ $0 | EDGAR |
| 2026-03-31 | 4 | Adaptive Biotechnologies Corp (ADPT) | Option exercise (M): 14,722 @ $7.27 · Sale (S): 2,738 @ $12.49 · Sale (S): 16,322 @ $13.48 · Option exercise (M): 14,722 @ $7.27 · Sale (S): 19,060 @ $12.63 · Option exercise (M): 14,722 @ $7.27 · +4 more | EDGAR |
| 2026-03-26 | 4 | Adaptive Biotechnologies Corp (ADPT) | Option exercise (M): 14,722 @ $7.27 · Sale (S): 19,060 @ $13.70 · Option exercise (M): 14,722 @ $7.27 · Sale (S): 19,060 @ $14.27 · Option exercise (M): 14,722 @ $7.27 · Sale (S): 19,060 @ $14.12 · +3 more | EDGAR |
| 2026-03-23 | 4 | Adaptive Biotechnologies Corp (ADPT) | Option exercise (M): 14,722 @ $6.55 · Sale (S): 19,060 @ $13.18 · Option exercise (M): 3,939 @ $6.55 · Option exercise (M): 10,783 @ $7.27 · Sale (S): 19,060 @ $13.37 · Option exercise (M): 14,722 @ $7.27 · +5 more | EDGAR |
| 2026-03-18 | 4 | Adaptive Biotechnologies Corp (ADPT) | Option exercise (M): 14,722 @ $6.55 · Sale (S): 19,060 @ $13.41 · Option exercise (M): 14,722 @ $6.55 · Sale (S): 19,060 @ $13.40 · Option exercise (M): 14,722 @ $6.55 · Sale (S): 19,060 @ $13.18 · +3 more | EDGAR |
| 2026-03-13 | 4 | Adaptive Biotechnologies Corp (ADPT) | Sale (S): 122,523 @ $13.17 · Option exercise (M): 14,722 @ $6.55 · Sale (S): 19,060 @ $14.08 · Option exercise (M): 14,722 @ $6.55 · Sale (S): 13,660 @ $12.63 · Sale (S): 5,400 @ $13.43 · +5 more | EDGAR |
| 2026-03-10 | 4 | Adaptive Biotechnologies Corp (ADPT) | Option exercise (M): 14,722 @ $6.55 · Option exercise (M): 11,881 @ $12.14 · Sale (S): 30,941 @ $15.14 · Option exercise (M): 14,722 @ $6.55 · Option exercise (M): 11,881 @ $12.14 · Sale (S): 30,941 @ $14.79 · +9 more | EDGAR |
| 2026-03-06 | 4 | Adaptive Biotechnologies Corp (ADPT) | Grant/award (A): 81,250 @ $0 | EDGAR |
| 2026-03-05 | 4 | Adaptive Biotechnologies Corp (ADPT) | Option exercise (M): 14,722 @ $6.55 · Option exercise (M): 11,881 @ $12.14 · Sale (S): 24,423 @ $15.49 · Sale (S): 6,518 @ $16.33 · Option exercise (M): 14,722 @ $6.55 · Option exercise (M): 11,881 @ $12.14 · +10 more | EDGAR |
| 2025-03-06 | 4 | Adaptive Biotechnologies Corp (ADPT) | Grant/award (A): 175,000 @ $0 · Sale (S): 40,044 @ $6.98 · Sale (S): 19,461 @ $6.99 | EDGAR |
| 2024-03-06 | 4 | Adaptive Biotechnologies Corp (ADPT) | Grant/award (A): 175,000 @ $0 · Sale (S): 25,580 @ $3.43 · Sale (S): 13,490 @ $3.56 | EDGAR |
| 2023-03-08 | 4 | Adaptive Biotechnologies Corp (ADPT) | Grant/award (A): 132,979 @ $0 · Sale (S): 22,668 @ $8.57 · Grant/award (A): 199,549 (derivative) @ $0 | EDGAR |
| 2022-03-08 | 4 | Adaptive Biotechnologies Corp (ADPT) | Grant/award (A): 185,338 @ $0 · Sale (S): 4,613 @ $12.01 · Grant/award (A): 463,344 (derivative) @ $0 | EDGAR |
| 2021-03-08 | 4 | Adaptive Biotechnologies Corp (ADPT) | Grant/award (A): 45,788 @ $0 · Grant/award (A): 114,469 (derivative) @ $0 | EDGAR |
| 2021-03-03 | 4 | Adaptive Biotechnologies Corp (ADPT) | Option exercise (M): 15,000 @ $6.55 · Sale (S): 4,684 @ $57.54 · Sale (S): 9,471 @ $58.64 · Sale (S): 845 @ $58.99 · Option exercise (M): 15,000 (derivative) @ $0 | EDGAR |
| 2021-03-01 | 4 | Adaptive Biotechnologies Corp (ADPT) | Option exercise (M): 15,000 @ $6.55 · Sale (S): 15,000 @ $56.23 · Option exercise (M): 15,000 (derivative) @ $0 | EDGAR |
| 2021-02-26 | 4 | Adaptive Biotechnologies Corp (ADPT) | Option exercise (M): 15,000 @ $6.55 · Sale (S): 4,234 @ $56.45 · Sale (S): 4,134 @ $57.12 · Sale (S): 3,374 @ $58.74 · Sale (S): 3,258 @ $59.33 · Option exercise (M): 14,675 @ $6.55 · +4 more | EDGAR |
| 2021-02-24 | 4 | Adaptive Biotechnologies Corp (ADPT) | Option exercise (M): 15,000 @ $6.55 · Sale (S): 9,844 @ $59.28 · Sale (S): 4,100 @ $60.21 · Sale (S): 400 @ $61.01 · Sale (S): 656 @ $62.20 · Option exercise (M): 15,000 @ $6.55 · +5 more | EDGAR |
| 2021-02-22 | 4 | Adaptive Biotechnologies Corp (ADPT) | Option exercise (M): 15,000 @ $6.55 · Sale (S): 3,499 @ $61.47 · Sale (S): 7,708 @ $62.30 · Sale (S): 3,793 @ $63.03 · Option exercise (M): 15,000 (derivative) @ $0 | EDGAR |
| 2021-02-19 | 4 | Adaptive Biotechnologies Corp (ADPT) | Option exercise (M): 15,000 @ $6.55 · Sale (S): 5,201 @ $61.63 · Sale (S): 9,799 @ $62.28 · Option exercise (M): 15,000 @ $6.55 · Sale (S): 5,892 @ $60.49 · Sale (S): 9,108 @ $61.20 · +2 more | EDGAR |
| 2021-02-17 | 4 | Adaptive Biotechnologies Corp (ADPT) | Option exercise (M): 15,000 @ $6.55 · Sale (S): 1,949 @ $64.53 · Sale (S): 3,130 @ $65.55 · Sale (S): 9,621 @ $66.38 · Sale (S): 300 @ $67 · Option exercise (M): 15,000 @ $6.55 · +4 more | EDGAR |
| 2021-02-12 | 4 | Adaptive Biotechnologies Corp (ADPT) | Option exercise (M): 15,000 @ $6.55 · Sale (S): 6,770 @ $62.14 · Sale (S): 3,814 @ $63 · Sale (S): 3,798 @ $64.09 · Sale (S): 618 @ $64.76 · Option exercise (M): 15,000 @ $6.55 · +4 more | EDGAR |
| 2021-02-10 | 4 | Adaptive Biotechnologies Corp (ADPT) | Option exercise (M): 15,000 @ $6.32 · Sale (S): 10,656 @ $61.96 · Sale (S): 4,344 @ $62.43 · Option exercise (M): 10,000 @ $6.55 · Option exercise (M): 5,000 @ $6.32 · Sale (S): 7,611 @ $61.81 · +4 more | EDGAR |
| 2021-02-08 | 4 | Adaptive Biotechnologies Corp (ADPT) | Option exercise (M): 15,000 @ $6.32 · Sale (S): 5,150 @ $59.64 · Sale (S): 9,850 @ $60.12 · Option exercise (M): 15,000 (derivative) @ $0 | EDGAR |
| 2021-02-05 | 4 | Adaptive Biotechnologies Corp (ADPT) | Option exercise (M): 15,000 @ $6.32 · Sale (S): 8,655 @ $59.39 · Sale (S): 5,435 @ $60.16 · Sale (S): 910 @ $60.82 · Option exercise (M): 15,000 @ $6.32 · Sale (S): 8,305 @ $58.77 · +3 more | EDGAR |
| 2021-02-03 | 4 | Adaptive Biotechnologies Corp (ADPT) | Option exercise (M): 15,000 @ $6.32 · Sale (S): 10,945 @ $55.36 · Sale (S): 4,055 @ $56.01 · Option exercise (M): 15,000 @ $6.32 · Sale (S): 7,710 @ $58.58 · Sale (S): 5,280 @ $59.20 · +3 more | EDGAR |
| 2021-02-01 | 4 | Adaptive Biotechnologies Corp (ADPT) | Option exercise (M): 15,000 @ $6.32 · Sale (S): 8,294 @ $55.77 · Sale (S): 4,910 @ $56.60 · Sale (S): 1,796 @ $57.74 · Option exercise (M): 15,000 (derivative) @ $0 | EDGAR |
| 2021-01-29 | 4 | Adaptive Biotechnologies Corp (ADPT) | Option exercise (M): 15,000 @ $6.32 · Sale (S): 6,387 @ $58.19 · Sale (S): 6,913 @ $59.37 · Sale (S): 1,700 @ $59.99 · Option exercise (M): 15,000 @ $6.32 · Sale (S): 3,433 @ $54.96 · +4 more | EDGAR |
| 2021-01-27 | 4 | Adaptive Biotechnologies Corp (ADPT) | Option exercise (M): 15,000 @ $6.32 · Sale (S): 3,871 @ $65.09 · Sale (S): 1,813 @ $65.89 · Sale (S): 8,816 @ $67.05 · Sale (S): 500 @ $67.79 · Option exercise (M): 15,000 @ $6.32 · +5 more | EDGAR |
| 2021-01-25 | 4 | Adaptive Biotechnologies Corp (ADPT) | Option exercise (M): 15,000 @ $6.32 · Sale (S): 5,524 @ $66.23 · Sale (S): 9,476 @ $67.19 · Option exercise (M): 15,000 (derivative) @ $0 | EDGAR |
| 2021-01-22 | 4 | Adaptive Biotechnologies Corp (ADPT) | Option exercise (M): 15,000 @ $6.32 · Sale (S): 6,444 @ $66.15 · Sale (S): 8,511 @ $66.87 · Sale (S): 45 @ $67.63 · Option exercise (M): 15,000 (derivative) @ $0 | EDGAR |
| 2021-01-21 | 4 | Adaptive Biotechnologies Corp (ADPT) | Option exercise (M): 15,000 @ $6.32 · Sale (S): 2,563 @ $68.72 · Sale (S): 7,415 @ $69.54 · Sale (S): 4,822 @ $70.51 · Sale (S): 200 @ $71.23 · Option exercise (M): 15,000 @ $6.32 · +5 more | EDGAR |
| 2021-01-20 | 4 | Adaptive Biotechnologies Corp (ADPT) | Option exercise (M): 15,000 @ $6.32 · Sale (S): 4,707 @ $65.47 · Sale (S): 8,802 @ $66.47 · Sale (S): 1,491 @ $67.19 · Option exercise (M): 15,000 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2020-09-28 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1780664 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs